Background and aim Sarcopenia is a multifactorial metabolic-mediated complication that
affects most of the geriatric population physically and mentally. In this study, we intended to …

OBJECTIVE We examined prevalence of sarcopenia in Korean patients with type 2 diabetes
and compared body compositional parameters between subjects with and without type 2 …

The term sarcopenia refers to the loss of muscle mass that occurs with ageing. On the basis
of study results showing that muscle mass is only moderately related to functional outcomes …

Ageing, obesity and the metabolic syndrome (MetS) may all contribute to poor muscle health
(sarcopenia). This study aimed to determine the cross-sectional associations between MetS …

Insulin resistance (IR) in skeletal muscle is a key defect mediating the link between obesity
and type 2 33 diabetes, a disease that typically affects people in later life. Sarcopenia (age …

At the present time, there is only limited understanding of the public health significance of
sarcopenia. The well-recognized functional consequences of sarcopenia include gait and …

Summary According to European Working Group on Sarcopenia in Older People (EWGSOP)
sarcopenia includes both a loss of muscle strength and a decline in functional quality in …

Aging is associated with sarcopenia. The loss of strength results in decreased muscle mass
and motor function. This process accelerates the progressive muscle deterioration observed …

Background: Sarcopenia is a pathophysiological condition diffused in elderly people; it
represents a social issue due to the longer life expectancy and the growing aging …

Sarcopenia is the loss of muscle mass that happens to everyone with age. However, the rate
of sarcopenia and the severity of its sequelae vary greatly according to health status …